Home > > Global Blood Screening Market Report
The Blood Screening market was valued at $2,859.8 Million in 2023, and is projected to reach $5,019.8 Million by 2030 growing at a CAGR of 8.44% from 2024 to 2030. Reagents and Kits segment is expected to be the highest contributor to this market, with $2,189.7 Million in 2023, and is anticipated to reach $3,848.2 Million by 2030, registering a CAGR of 8.46%. Instruments segment is anticipated to reach $875.2 Million by 2030 with the highest CAGR of 8.47%. Reagents and Kits and Instruments segments collectively expected to account for about 94.0% share of the Blood Screening market in 2023, with the former constituting around 76.6% share. Instruments and Reagents and Kits segments are expected to witness significant growth rates at a CAGR of 8.47% and 8.46% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 94.0% in the overall Blood Screening market in 2023, and is anticipated to reach 94.1% by 2030. Product & Service Reagents and Kits Instruments Software and Services Technology NAT ELISA Rapid Tests Western Blot Assays NGS End User Blood Banks Hospitals BY REGION North America U.s. Canada Europe Germany France U.k. Italy Spain RoE Asia Japan China India Australia RoAPAC Middle East & Africa Latin America MEA